These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35491147)

  • 1. [Recent Advances in the Studies of Metabolic Syndromes and Applications to the Development of New Drugs].
    Kushiyama A; Nakatsu Y
    Yakugaku Zasshi; 2022; 142(5):447-448. PubMed ID: 35491147
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin for Antipsychotic-Related Metabolic Syndrome in Children: Fact or Fiction?
    Naguy A; El-Sori D
    Chin Med J (Engl); 2018 Jun; 131(12):1490-1491. PubMed ID: 29893366
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitamin D and metabolic syndrome: is there a link?
    Florentin M; Elisaf MS; Mikhailidis DP; Liberopoulos EN
    Curr Pharm Des; 2010 Oct; 16(30):3417-34. PubMed ID: 20819071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone antagonist decreases blood pressure and improves metabolic parameters in obese patients with the metabolic syndrome.
    Costa MB; Andrade Ezequiel DG; Morais Lovis JC; Oliveira MM; Baumgratz de Paula R
    J Clin Hypertens (Greenwich); 2010 Sep; 12(9):753-5. PubMed ID: 20883238
    [No Abstract]   [Full Text] [Related]  

  • 5. High fructose diet-induced metabolic syndrome: Pathophysiological mechanism and treatment by traditional Chinese medicine.
    Pan Y; Kong LD
    Pharmacol Res; 2018 Apr; 130():438-450. PubMed ID: 29471102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological function of leptin and obesity-related diseases].
    Ogawa Y
    Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2435-41. PubMed ID: 15624484
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin resistance and heart failure: molecular mechanisms.
    Aroor AR; Mandavia CH; Sowers JR
    Heart Fail Clin; 2012 Oct; 8(4):609-17. PubMed ID: 22999243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and metabolic syndrome.
    D'Aversa F; Tortora A; Ianiro G; Ponziani FR; Annicchiarico BE; Gasbarrini A
    Intern Emerg Med; 2013 Apr; 8 Suppl 1():S11-5. PubMed ID: 23468402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of Chinese prescription Kangen-karyu for patient with lifestyle-induced metabolic syndrome.
    Park CH; Kitazawa T; Futamura A; Hirana H; Shoji M; Osanai M; Yokozawa T
    Drug Discov Ther; 2020 Nov; 14(5):252-255. PubMed ID: 33116040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracellular signal transduction of vascular injury in insulin resistance].
    Yoshizumi M; Ishizawa K; Izawa Y; Tamaki T
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):147-52. PubMed ID: 16971777
    [No Abstract]   [Full Text] [Related]  

  • 11. Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements.
    Kumari B; Yadav UCS
    Curr Mol Med; 2018; 18(2):116-125. PubMed ID: 29974830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
    Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS
    Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing New Use for Old Drug Chloroquine against Metabolic Syndrome: A Review on Animal and Human Evidence.
    Wong SK
    Int J Med Sci; 2021; 18(12):2673-2688. PubMed ID: 34104100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Microvascular Dysfunction and Inflammation Are Improved by Centrally Acting Antihypertensive Drugs in Metabolic Syndrome.
    Estato V; Nascimento A; Antunes B; Gomes F; Coelho L; Rangel R; Garzoni L; Daliry A; Bousquet P; Tibiriçá E
    Metab Syndr Relat Disord; 2017 Feb; 15(1):26-35. PubMed ID: 27929741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal alkaline phosphatase prevents metabolic syndrome in mice.
    Kaliannan K; Hamarneh SR; Economopoulos KP; Nasrin Alam S; Moaven O; Patel P; Malo NS; Ray M; Abtahi SM; Muhammad N; Raychowdhury A; Teshager A; Mohamed MM; Moss AK; Ahmed R; Hakimian S; Narisawa S; Millán JL; Hohmann E; Warren HS; Bhan AK; Malo MS; Hodin RA
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):7003-8. PubMed ID: 23569246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines: therapeutic targets for metabolic syndrome.
    Kobayashi K
    Curr Drug Targets; 2005 Jun; 6(4):525-9. PubMed ID: 16026271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress.
    Spahis S; Borys JM; Levy E
    Antioxid Redox Signal; 2017 Mar; 26(9):445-461. PubMed ID: 27302002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets.
    Iannucci CV; Capoccia D; Calabria M; Leonetti F
    Curr Pharm Des; 2007; 13(21):2148-68. PubMed ID: 17627547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets and mechanisms of bioactive peptides against metabolic syndromes.
    Li S; Liu L; He G; Wu J
    Food Funct; 2018 Jan; 9(1):42-52. PubMed ID: 29188845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and osteoarthritis pain: common molecular mechanisms and potential therapeutic implications.
    Valdes AM
    Osteoarthritis Cartilage; 2020 Jan; 28(1):7-9. PubMed ID: 31408694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.